Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.

The Department of Cardiothoracic Surgery is a recognized leader in heart, lung and esophagus surgery. Our experience with complex cardiothoracic issues and knowledge of the latest advances have helped to establish NewYork-Presbyterian|Weill Cornell Medicine as a major referral center for cardiovascular and thoracic patients from around the world.

Cardiothoracic surgery group photo

Cardiac Surgery

The Division of Cardiac Surgery provides expert care to patients who need:

  • Coronary artery bypass surgery
  • Valve repair/replacement
  • Surgery for adult congenital heart disease
  • Minimally Invasive Heart Surgery
  • Ventricular Assist Devices (VADs)
Learn More
Cardiac Surgery team

Thoracic Surgery

The Division of Thoracic Surgery offers the most advanced surgical care for:

  • Lung and esophageal cancers
  • Emphysema
  • Hyperhidrosis
  • Hiatal hernia
  • Pericardial & Pleural Effusions
  • Thoracentesis
Learn More
Thoracic Surgery team

Why Choose Weill Cornell?

NewYork-Presbyterian & Weill Cornell Medicine - Cardiothoracic Surgery

New Advances

Scientists Find a New Way to Reverse Immune Suppression in Tumors

two men posing for a photo

Drs. Vivek Mittal (left) and Dingcheng Gao

Malignant tumors can enhance their ability to survive and spread by suppressing antitumor immune cells in their vicinity, but a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian has uncovered a new way to counter this immunosuppressive effect.

In the study, published Sept. 20 in Nature Cancer, the researchers identified a set of anti-immunosuppressive factors that can be secreted by cells called club cells that line airways in the lungs. They showed in a mouse model of lung cancer that these club cell factors inhibit highly potent immunosuppressive cells called myeloid-derived suppressor cells (MDSCs), which tumors often recruit to help them evade antitumor immune responses.

The inhibition of the MDSCs led to an increase in the number of antitumor T cells at the tumor site, and greatly improved the effectiveness of FDA approved PD1 immunotherapy. 

“These club cell-secreted factors are able to nullify immune suppressor cells that otherwise help tumors escape an effective antitumor response,” said co-senior author Dr. Vivek Mittal, director of research at the Neuberger Berman Lung Cancer Center and the Ford-Isom Research Professor of Cardiothoracic Surgery at Weill Cornell Medicine. “We’re excited by the possibility of developing these club cell factors into a cancer treatment.” Click Here to read the full article. 

TWIST - Designing an International Multi-center Trial

Evaluating therapeutic approaches through clinical research can be done at many different scales; some exploratory studies seek to enroll just a handful of participants at a single site while other ideas require a great deal more statistical power. Thankfully multi-center and international collaborations are an excellent source of that power! Join our Director Dr. Mario Gaudino on Tuesday August 17th for a look at his work and experience designing and running a trial that spans over 50 countries!

Presented by

Mario F. L. Gaudino, MD

Director, Joint Clinical Trials Office 

Time: Aug 17, 2021 02:00 PM Eastern Time (US and Canada)

Join Zoom Meeting

https://weillcornell.zoom.us/j/94207946257

Meeting ID: 942 0794 6257

One tap mobile

+16468769923,,94207946257# US (New York)

+13017158592,,94207946257# US (Washington DC)

Donor Spotlight: Supporting a Culture of Caring

Hamms photo

Charles Hamm recently underwent open-heart surgery with Dr. Stephanie Mick of NewYork-Presbyterian/Weill Cornell Medical Center to remove the melanoma that had metastasized inside his heart. 

Inspired by the dedication and compassion they experienced via lifelong connections with their physicians, Mr. and Mrs. Hamm recently made a gift of $1 million in honor of Dr. Mick and the other NewYork-Presbyterian/Weill Cornell physicians who saved Charles’ life: Drs. Leonard Girardi, David Blumenthal, and Richard Cohen.

Read More

2021 NYC Walk For Victory

Join us at the Hudson River Park, Saturday, June 5th for the annual Marfan Foundation's global walk program. Click here for more details. 

2021 Walk for Victory

Clinical Trials

The Cardiothoracic Surgery Department conducts a robust clinical trials program to evaluate the effectiveness of new treatments and medications that have the potential to improve the management of patients with heart, lung, and esophageal disease. The outcomes of heart, lung, and esophageal operations can be improved with technical innovations.

Current Clinical Trials

 

US News Cardiology & Heart Surgery Badge

The Weill Cornell Medicine's Department of Cardiothoracic Surgery is proud to partner with NewYork-Presbyterian, ranked #4 in Adult Cardiology & Heart Surgery Hospital in the nation and #1 in NYC by U.S. News and World Report.